Scholar Rock Secures $36m Investment And Janssen IO Option

Biotech company Scholar Rock has announced a $36m series B financing to fund 2016 plans. Its partner Janssen Biotech, Inc. has also decided to exercise an option in the pair's immune-oncology collaboration.